- Home
- WSR vs ANL Comparison
WSR vs ANL Comparison
Compare WSR & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WSR | ANL |
|---|---|---|
| Founded | 1998 | 2004 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 835.1M | 703.3M |
| IPO Year | 2002 | 2022 |
Fundamental Metrics
Financial Performance| Metric | WSR | ANL |
|---|---|---|
| Price | $18.94 | $13.94 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $19.00 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 718.2K | 693.8K |
| Earning Date | 05-01-2026 | 04-10-2026 |
| Dividend Yield | ★ 3.01% | N/A |
| EPS Growth | ★ 31.94 | N/A |
| EPS | ★ 0.95 | N/A |
| Revenue | ★ $160,859,000.00 | N/A |
| Revenue This Year | $2.77 | $36.02 |
| Revenue Next Year | $4.21 | N/A |
| P/E Ratio | $19.92 | ★ N/A |
| Revenue Growth | ★ 4.26 | N/A |
| 52 Week Low | $11.43 | $0.88 |
| 52 Week High | $19.00 | $17.25 |
Technical Indicators
Market Signals| Indicator | WSR | ANL |
|---|---|---|
| Relative Strength Index (RSI) | 82.10 | 56.05 |
| Support Level | $15.90 | $1.36 |
| Resistance Level | N/A | $17.25 |
| Average True Range (ATR) | 0.04 | 2.58 |
| MACD | -0.06 | -0.24 |
| Stochastic Oscillator | 58.62 | 65.07 |
Price Performance
Historical ComparisonAbout WSR Whitestone REIT
Whitestone REIT is a real estate investment trust (REIT) that owns and operates commercial properties in culturally diverse metropolitan markets. The company's primary business objective is to increase shareholder value by acquiring, owning, and operating Community Centered Properties. Its property portfolio includes retail and mixed-use properties located in business-friendly locations in and around Austin, Scottsdale, Dallas, Houston, Phoenix, Arizona, and San Antonio. The properties are convenience-focused: merchandised with a mix of service-oriented tenants providing food (restaurants and grocers), self-care (health and fitness), services (financial and logistics), education, and entertainment to the surrounding communities.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.